Related Content
Search Google Scholar for:
|
|
Science 17 March 1989: Vol. 243. no. 4897, pp. 1471 - 1474 DOI: 10.1126/science.2522679
|
|
Articles
Science, Vol 243, Issue 4897, 1471-1474
Copyright © 1989 by American Association for the Advancement of Science
The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease
R Navon
and
RL Proia
Genetics and Biochemistry Branch, National Institute of Diabetes, Digestive, and Kidney Diseases, Bethesda, MD 20892.
The adult form of Tay-Sachs disease, adult GM2 gangliosidosis, is an autosomal recessive disorder that results from mutations in the alpha chain of beta-hexosaminidase A. This disorder, like infantile Tay-Sachs disease, is more frequent in the Ashkenazi Jewish population. A point mutation in the alpha-chain gene was identified that results in the substitution of Gly with Ser in eight Ashkenazi adult GM2 gangliosidosis patients from five different families. This amino acid substitution was shown to depress drastically the catalytic activity of the alpha chain after expression in COS-1 cells. All of these patients proved to be compound heterozygotes of the allele with the Gly to Ser change and one of the two Ashkenazi infantile Tay-Sachs alleles. These findings will aid in the diagnosis and understanding of beta-hexosaminidase A deficiency disorders.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Pyrimethamine as a Potential Pharmacological Chaperone for Late-onset Forms of GM2 Gangliosidosis.
- G. H. B. Maegawa, M. Tropak, J. Buttner, T. Stockley, F. Kok, J. T. R. Clarke, and D. J. Mahuran (2007)
J. Biol. Chem.
282, 9150-9161
| Abstract »
| Full Text »
| PDF »
- Evaluation of the Risk for Tay-Sachs Disease in Individuals of French Canadian Ancestry Living in New England.
- D. C. Martin, B. L. Mark, B. L. Triggs-Raine, and M. R. Natowicz (2007)
Clin. Chem.
53, 392-398
| Abstract »
| Full Text »
| PDF »
- Diagnosis and Molecular Characterization of Nonclassic Forms of Tay-Sachs Disease in Brazil.
- R. Rozenberg, F. Kok, M.G. Burin, M.C. Sa Miranda, C. Vasques, A.M.M. Henriques-Souza, R. Giugliani, M. Vainzof, and L.V. Pereira (2006)
J Child Neurol
21, 540-544
| Abstract »
| PDF »
- Neuro-ophthalmology of late-onset Tay-Sachs disease (LOTS).
- J. C. Rucker, B. E. Shapiro, Y. H. Han, A. N. Kumar, S. Garbutt, E. L. Keller, and R. J. Leigh (2004)
Neurology
63, 1918-1926
| Abstract »
| Full Text »
| PDF »
- 31Phosphorus Magnetic Resonance Spectroscopy in Late-Onset Tay-Sachs Disease.
- U. Felderhoff-Mueser, J. Sperner, P. Konstanzcak, R. Navon, and B. Weschke (2001)
J Child Neurol
16, 377-380
| Abstract »
| PDF »
- A Pro504 right-arrow Ser Substitution in the beta -Subunit of beta -Hexosaminidase A Inhibits alpha -Subunit Hydrolysis of GM2 Ganglioside, Resulting in Chronic Sandhoff Disease.
- Y. Hou, B. McInnes, A. Hinek, G. Karpati, and D. Mahuran (1998)
J. Biol. Chem.
273, 21386-21392
| Abstract »
| Full Text »
| PDF »
- Neuropsychiatric Aspects of the Adult Variant of Tay-Sachs Disease.
- G. M. MacQueen, P. I. Rosebush, and M. F. Mazurek (1998)
J Neuropsychiatry Clin Neurosci
10, 10-19
| Abstract »
| Full Text »
- Prenatal Genetic Carrier Testing Using Triple Disease Screening.
- C. M. Eng, C. Schechter, J. Robinowitz, G. Fulop, T. Burgert, B. Levy, R. Zinberg, and R. J. Desnick (1997)
JAMA
278, 1268-1272
| Abstract »
| PDF »
- Benign HEXA Mutations, C739T(R247W) and C745T(R249W), Cause beta -Hexosaminidase A Pseudodeficiency by Reducing the alpha -Subunit Protein Levels.
- Z. Cao, E. Petroulakis, T. Salo, and B. Triggs-Raine (1997)
J. Biol. Chem.
272, 14975-14982
| Abstract »
| Full Text »
| PDF »
- Identification of Candidate Active Site Residues in Lysosomal beta -Hexosaminidase A.
- M. J.G. Fernandes, S. Yew, D. Leclerc, B. Henrissat, C. E. Vorgias, R. A. Gravel, P. Hechtman, and F. Kaplan (1997)
J. Biol. Chem.
272, 814-820
| Abstract »
| Full Text »
| PDF »
- A simplified procedure for developing multiplex PCRs..
- A P Shuber, V J Grondin, and K W Klinger (1995)
Genome Res.
5, 488-493
| Abstract »
| PDF »
|
|